Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy-Reference-Cited by-同舟云学术

Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy

Published:2018-04 Issue:2 Volume:16 Page:e491-e496
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Morote Juan,Comas Inma,Planas Jacques,Maldonado Xavier,Celma Ana,Placer José,Ferrer Roser,Carles Joan,Regis Lucas

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference24 articles.

1. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013;Heidenreich;Eur Urol,2014

2. Leuprolide versus diethylstilbestrol for metastatic prostate cancer;The Leuprolide Study Group;N Engl J Med,1984

3. Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making;Oefelein;Urology,2000

4. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy;Morote;J Urol,2007

5. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children;Taieb;Clin Chem,2003

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer;npj Breast Cancer;2024-01-19

2. Hormone Therapy for Advanced Prostate Cancer;Prostate Cancer;2024

3. The Need for Serum Testosterone Measurement with Liquid Chromatography and Tandem Mass Spectrometry in Prostate Cancer Patients Undergoing Castration;European Urology Oncology;2023-09

4. Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review;Cancers;2023-07-03

5. Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level;Journal of Urology;2022-12